The world is experiencing a hidden epidemic with kidney disease. More than 850 million people worldwide have some form of kidney disease, which is roughly double the number of people who live with ...

A new product approval may be right around the corner.

VERTEX International Securities (Vertex) held the Capital Market Review on Friday, February 27, 2026, to assess the ...

Besting Vertex Pharmaceuticals’ kidney disease asset wasn’t enough to impress Wall Street, which appears to be “getting hung ...

For those who recall the debate surrounding Microsoft Recall not long ago, Claude Code's capture of activity is similar.

Investors had reservations about data for a drug that could compete with a candidate from Vertex in APOL1-mediated kidney ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

Sal Visca of Vertex explains why tax professionals and authorities must evolve to keep pace with developments such as ...

The Emirate of Abu Dhabi has achieved a series of significant medical and scientific milestones during the first quarter of ...

Publicly accusing an entity of a cyberattack could have negative consequences that organizations should consider before ...

Four former NSA chiefs representing a near-complete history of US Cyber Command debated and discussed the role of offensive ...